Cargando…

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer

Recently, Dclk1 expression was identified to be an intestinal cancer stem cell specific biomarker in mouse models, implicating a potential role for targeting the DCLK1-postive cancer cells as a treatment for colorectal cancer. Using quantitative methylation specific PCR (qMSP) we here demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vedeld, Hege Marie, Skotheim, Rolf I, Lothe, Ragnhild A, Lind, Guro E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053453/ https://www.ncbi.nlm.nih.gov/pubmed/24384857 http://dx.doi.org/10.4161/epi.27582

Ejemplares similares

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
por: Flatin, Bjørnar T.B., et al.
Publicado: (2020)

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
por: Cekaite, Lina, et al.
Publicado: (2015)

Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
por: Vedeld, Hege Marie, et al.
Publicado: (2017)

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011)

Phospholipase C Isozymes Are Deregulated in Colorectal Cancer – Insights Gained from Gene Set Enrichment Analysis of the Transcriptome
por: Danielsen, Stine A., et al.
Publicado: (2011)

Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
por: Ahlquist, Terje, et al.
Publicado: (2008)

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
por: Vedeld, Hege Marie, et al.
Publicado: (2017)

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers
por: Vedeld, Hege Marie, et al.
Publicado: (2020)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

Analysis of the clinical significance of DCLK1(+) colorectal cancer using novel monoclonal antibodies against DCLK1
por: Dai, Tianqi, et al.
Publicado: (2018)

ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis
por: Lind, Guro E., et al.
Publicado: (2006)

Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
por: Bethge, Nicole, et al.
Publicado: (2014)

Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array-CGH, and Associated Gene Expression Changes
por: Skotheim, Rolf I., et al.
Publicado: (2006)

Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients
por: Lind, Guro E., et al.
Publicado: (2017)

Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
por: Kleivi, Kristine, et al.
Publicado: (2007)

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011)

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
por: Berg, Kaja C. G., et al.
Publicado: (2017)

DCLK1 immunoreactivity in colorectal neoplasia
por: Gagliardi, Giuseppe, et al.
Publicado: (2012)

Hypermethylated MAL gene – a silent marker of early colon tumorigenesis
por: Lind, Guro E, et al.
Publicado: (2008)

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas
por: Sveen, Anita, et al.
Publicado: (2014)

Novel RNA variants in colorectal cancers
por: Hoff, Andreas M., et al.
Publicado: (2015)

DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
por: Mohammadi, Chiman, et al.
Publicado: (2021)

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
por: Marie Vedeld, Hege, et al.
Publicado: (2015)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer
por: Vijai, Muthu, et al.
Publicado: (2021)

PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data
por: Jeanmougin, Marine, et al.
Publicado: (2022)

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2012)

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation
por: Pinto, Diana, et al.
Publicado: (2018)

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity
por: Kidd, Susanne G., et al.
Publicado: (2021)

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection
por: Kolberg, Matthias, et al.
Publicado: (2015)

Application of RNA Sequencing to identify transcriptome modification by DCLK1 in Colorectal Cancer Cells
por: Li, Lianna, et al.
Publicado: (2019)

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
por: Skotheim, Rolf I, et al.
Publicado: (2009)

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression
por: Roy, Badal Chandra, et al.
Publicado: (2019)

Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential
por: Almeida, Mafalda, et al.
Publicado: (2014)

Pleiotropic effects of DCLK1 in cancer and cancer stem cells
por: Chhetri, Dibyashree, et al.
Publicado: (2022)

High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
por: IKEZONO, YU, et al.
Publicado: (2015)

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_alvvvljpuj4fosp844q7bsbpnv